Apolipoprotein Antikörper und Ähnliche Produkte
Santa Cruz Biotechnology bietet eine umfassende Sammlung von monoklonalen Apolipoprotein-Antikörpern für verschiedene Forschungsanwendungen. Die monoklonalen Apolipoprotein-Antikörper eignen sich für Western Blotting (WB), Immunpräzipitation (IP), Immunfluoreszenz (IF), Immunhistochemie mit in Paraffin eingebetteten Schnitten (IHCP), Durchflusszytometrie (FCM) und Enzyme-Linked Immunosorbent Assay (ELISA). Apolipoproteine spielen eine entscheidende Rolle im Lipidstoffwechsel und sind für den Transport und die Clearance von Lipoproteinen im Blutkreislauf unerlässlich. Apolipoproteine dienen als strukturelle Komponenten von Lipoproteinen und wirken als Liganden für Rezeptoren, die die Cholesterinhomöostase und die kardiovaskuläre Gesundheit beeinflussen. Das Verständnis der Funktion von Apolipoproteinen ist von entscheidender Bedeutung für die Aufklärung der Mechanismen, die Stoffwechselstörungen und Herz-Kreislauf-Erkrankungen zugrunde liegen. Die Apolipoprotein-Forschung bringt immer wieder neue Erkenntnisse über den Lipidstoffwechsel und seine Auswirkungen auf die menschliche Gesundheit zutage. Forscher, die lipidbezogene Störungen untersuchen, können sich auf monoklonale Apolipoprotein-Antikörper verlassen, um sie präzise nachzuweisen und zu charakterisieren. Die monoklonalen Antikörper von Santa Cruz Biotechnology für die Apolipoprotein-Forschung unterstützen Wissenschaftler dabei, unser Verständnis von Stoffwechsel- und Herz-Kreislauf-Erkrankungen zu verbessern.
Siehe auch...
ChemCruz™ Chemikalien Apolipoprotein Inhibitors für die funktionelle Analyse zellulärer Antworten auf Apolipoprotein
Apolipoprotein Antikörper
| Empty Table Header | Produkt | Katnr. | Isotyp | Epitop | Anwendungen | Species | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|---|
Apolipoprotein A I/APOA1 Antikörper (B-10) | sc-376818 | mouse IgG2b κ | FL (h) | WB, IP, IF, IHC(P), ELISA | h | 57 | ||
Apolipoprotein A I/APOA1 Antikörper (2G4) | sc-69755 | mouse IgG1 | (h) | WB, IP, IF, ELISA | m, r, h | 6 | ||
Apolipoprotein A I/APOA1 Antikörper (A5.4) | sc-13549 | mouse IgG1 | 113-243 (h) | WB, IP, IF, IHC(P) | h | 4 | ||
Apolipoprotein A I/APOA1 Antikörper (4) | sc-135837 | mouse IgG1 | 144-258 (r) | WB, IP | m, r | 1 | ||
Apolipoprotein A I/APOA1 Antikörper (G-11) | sc-376811 | mouse IgG1 κ | FL (h) | WB, IP, IF, IHC(P), ELISA | h | 3 | ||
Apolipoprotein A I/APOA1 Antikörper (464CT10.4.4) | sc-517307 | mouse IgG1 | 10-37 (h) | WB | m, r, h | neu | ||
apoA-II Antikörper (ZZ6) | sc-101261 | mouse IgG1 κ | 1-101 (h) | IF, IHC(P), ELISA | h | neu | ||
apoA-IV Antikörper (G-8) | sc-374543 | mouse IgG1 κ | C-Terminal (h) | WB, IP, IF, IHC(P), ELISA | h | 8 | ||
apoA-V Antikörper (A-12) | sc-393722 | mouse IgG1 κ | 321-336 (h) | WB, IP, IF, ELISA | m, r, h | neu | ||
apoA-V Antikörper (1G5G9) | sc-32809 | mouse IgG1 κ | (h) | WB, IP | h | neu | ||
apoA-V Antikörper (2G1H11) | sc-65991 | mouse IgG1 κ | (h) | WB, IP | h | neu | ||
apoA-V Antikörper (4H8H8E2) | sc-32810 | mouse IgG1 κ | (h) | WB, IP, IF, IHC(P), ELISA | h | neu | ||
apoA-V Antikörper (E-12) | sc-373950 | mouse IgG1 κ | 69-368 (m) | WB, IP, IF, ELISA | m | 3 | ||
apoA-V Antikörper (1F1E8) | sc-65992 | mouse IgG1 κ | (h) | WB | h | neu | ||
apoB Antikörper (C1.4) | sc-13538 | mouse IgG1 κ | 97-526 (h) | WB, IP, IF, IHC(P), ELISA | h | 23 | ||
apoB Antikörper (A-6) | sc-393636 | mouse IgG1 κ | 1-300 (h) | WB, IP, IF, ELISA | m, r, h | 29 | ||
apoC-I Antikörper (Y-13) | sc-101263 | mouse IgG1 κ | 1-84 (h) | WB, IP, ELISA | h | 4 | ||
apoC-II Antikörper (3E4) | sc-293340 | mouse IgG2a κ | 23-101 (h) | WB, IP, ELISA | h | neu | ||
apoC-III Antikörper (8H7) | sc-293227 | mouse IgG2a κ | 21-99 (h) | WB, IP, IF, ELISA | h | 2 | ||
apoC-IV Antikörper (7-RE36) | sc-134263 | mouse IgG2a κ | 27-128 (h) | WB, IP, ELISA | h | neu | ||
apoD Antikörper (C-1) | sc-373965 | mouse IgG2b κ | FL (h) | WB, IP, IF, IHC(P), ELISA | h | 4 | ||
apoD Antikörper (D-12) | sc-166612 | mouse IgG1 κ | FL (m) | WB, IP, IF, ELISA | m, r, h | 1 | ||
apolipoprotein E/apoE Antikörper (A1.4) | sc-13521 | mouse IgG1 κ | 126-191 (h) | WB, IP, IF, IHC(P) | h | 32 | ||
apolipoprotein E/apoE Antikörper (F-9) | sc-390925 | mouse IgG2a κ | 31-253 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 21 | ||
apolipoprotein E/apoE Antikörper (B-9) | sc-393773 | mouse IgG2a κ | 293-301 (r) | WB, IP, IF, IHC(P), ELISA | m, r | neu | ||
apolipoprotein E/apoE Antikörper (E-8) | sc-393302 | mouse IgG1 κ | 293-318 (h) | WB, IP, IF, ELISA | h | 2 | ||
apolipoprotein E/apoE Antikörper (H-4) | sc-393774 | mouse IgG1 κ | 293-301 (r) | WB, IP, IF, IHC(P), ELISA | m, r | neu | ||
apolipoprotein E/apoE Antikörper (WU E-4) | sc-53570 | mouse IgG1 κ | (h) | WB, IP, IF, IHC(P) | m, r, h | 13 | ||
apoF Antikörper (B-6) | sc-398151 | mouse IgG1 κ | 44-326 (m) | WB, IP, IF, ELISA | m | neu | ||
apoH Antikörper (C-2) | sc-515677 | mouse IgG2b κ | 182-340 (h) | WB, IP, IF, ELISA | m, r, h | 2 | ||
apoH Antikörper (1D2) | sc-58244 | mouse IgG1 | FL (h) | WB, IF, ELISA | h | 1 | ||
apoL1 Antikörper (A-3) | sc-390440 | mouse IgG1 κ | 201-285 (h) | WB, IP, IF, ELISA | h | 3 | ||
apoL3 Antikörper (L07) | sc-101262 | mouse IgG2a κ | 240-337 (h) | WB, IP, ELISA | h | neu | ||
apoM Antikörper (A-10) | sc-365139 | mouse IgG2a κ | FL (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 2 | ||
apoM Antikörper (D-4) | sc-398762 | mouse IgG2b κ | 163-186 (h) | WB, IP, IF, ELISA | m, r, h | 1 | ||
apoM Antikörper (8F12C6B8) | sc-81165 | mouse IgG1 κ | FL (h) | WB, IP, IF | m, r, h | neu | ||
apoOL Antikörper (G-6) | sc-390958 | mouse IgG2a κ | 239-262 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 2 |
Apolipoprotein CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
apoA Double Nickase Plasmid (h) | sc-404800-NIC | h | Gene Knockout | Puromycin | 0 | ||
apoA Double Nickase Plasmid (h2) | sc-404800-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
apoA-II Double Nickase Plasmid (h) | sc-404987-NIC | h | Gene Knockout | Puromycin | 0 | ||
apoA-II Double Nickase Plasmid (h2) | sc-404987-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
apoA-IV Double Nickase Plasmid (h) | sc-402217-NIC | h | Gene Knockout | Puromycin | 0 | ||
apoA-IV Double Nickase Plasmid (h2) | sc-402217-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
ApoA-V CRISPR/Cas9 KO Plasmid (h) | sc-402213 | h | Gene Knockout | GFP | 0 | ||
ApoA-V HDR Plasmid (h) | sc-402213-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
apoB CRISPR/Cas9 KO Plasmid (h2) | sc-400705-KO-2 | h | Gene Knockout | GFP | 0 | ||
apoB HDR Plasmid (h2) | sc-400705-HDR-2 | h | Homology Directed Repair | Puromycin | 0 | ||
apoB Double Nickase Plasmid (h) | sc-400705-NIC | h | Gene Knockout | Puromycin | 0 | ||
apoB Double Nickase Plasmid (h2) | sc-400705-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
apoB CRISPR/Cas9 KO Plasmid (m) | sc-433607 | m | Gene Knockout | GFP | 0 | ||
apoC-I CRISPR/Cas9 KO Plasmid (m) | sc-419163 | m | Gene Knockout | GFP | 0 | ||
apoC-I Double Nickase Plasmid (m) | sc-419163-NIC | m | Gene Knockout | Puromycin | 0 | ||
apoC-I Double Nickase Plasmid (m2) | sc-419163-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
apoC-II CRISPR/Cas9 KO Plasmid (m) | sc-419164 | m | Gene Knockout | GFP | 0 | ||
apoC-III Double Nickase Plasmid (h) | sc-403887-NIC | h | Gene Knockout | Puromycin | 0 | ||
apoC-III Double Nickase Plasmid (h2) | sc-403887-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
apoC-III CRISPR/Cas9 KO Plasmid (m) | sc-419165 | m | Gene Knockout | GFP | 0 | ||
apoC-III Double Nickase Plasmid (m) | sc-419165-NIC | m | Gene Knockout | Puromycin | 0 | ||
apoC-IV CRISPR/Cas9 KO Plasmid (m) | sc-418944 | m | Gene Knockout | GFP | 0 | ||
apoD CRISPR/Cas9 KO Plasmid (h) | sc-402012 | h | Gene Knockout | GFP | 0 | ||
apoD HDR Plasmid (h) | sc-402012-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
apoD Double Nickase Plasmid (h) | sc-402012-NIC | h | Gene Knockout | Puromycin | 0 | ||
apoD Double Nickase Plasmid (h2) | sc-402012-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
apoD CRISPR/Cas9 KO Plasmid (m) | sc-419166 | m | Gene Knockout | GFP | 0 | ||
apoF CRISPR/Cas9 KO Plasmid (h) | sc-407655 | h | Gene Knockout | GFP | 0 | ||
apoF HDR Plasmid (h) | sc-407655-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
apoF Double Nickase Plasmid (h) | sc-407655-NIC | h | Gene Knockout | Puromycin | 0 | ||
apoF Double Nickase Plasmid (h2) | sc-407655-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
apoH CRISPR/Cas9 KO Plasmid (m) | sc-419168 | m | Gene Knockout | GFP | 0 | ||
apolipoprotein E/apoE CRISPR/Cas9 KO Plasmid (h2) | sc-400860-KO-2 | h | Gene Knockout | GFP | 0 | ||
apolipoprotein E/apoE HDR Plasmid (h2) | sc-400860-HDR-2 | h | Homology Directed Repair | Puromycin | 0 | ||
apolipoprotein E/apoE Double Nickase Plasmid (h) | sc-400860-NIC | h | Gene Knockout | Puromycin | 0 | ||
apolipoprotein E/apoE Double Nickase Plasmid (h2) | sc-400860-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
apolipoprotein E/apoE CRISPR/Cas9 KO Plasmid (m) | sc-419167 | m | Gene Knockout | GFP | 0 | ||
apolipoprotein E/apoE Double Nickase Plasmid (m) | sc-419167-NIC | m | Gene Knockout | Puromycin | 0 | ||
apoO Double Nickase Plasmid (h) | sc-413137-NIC | h | Gene Knockout | Puromycin | 1 | ||
apoO Double Nickase Plasmid (h2) | sc-413137-NIC-2 | h | Gene Knockout | Puromycin | 1 | ||
apoO Double Nickase Plasmid (m) | sc-427017-NIC | m | Gene Knockout | Puromycin | 0 | ||
apoOL Double Nickase Plasmid (h) | sc-414464-NIC | h | Gene Knockout | Puromycin | 0 | ||
apoC1 Double Nickase Plasmid (h) | sc-403713-NIC | h | Gene Knockout | Puromycin | 0 | ||
apoC1 Double Nickase Plasmid (h2) | sc-403713-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
apoL1 CRISPR/Cas9 KO Plasmid (h) | sc-403137 | h | Gene Knockout | GFP | 0 | ||
apoL1 HDR Plasmid (h) | sc-403137-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
apoL1 Double Nickase Plasmid (h) | sc-403137-NIC | h | Gene Knockout | Puromycin | 0 | ||
apoL1 Double Nickase Plasmid (h2) | sc-403137-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
Apolipoprotein A I/APOA1 CRISPR/Cas9 KO Plasmid (h) | sc-400499 | h | Gene Knockout | GFP | 1 | ||
Apolipoprotein A I/APOA1 HDR Plasmid (h) | sc-400499-HDR | h | Homology Directed Repair | Puromycin | 1 | ||
Apolipoprotein A I/APOA1 Double Nickase Plasmid (h) | sc-400499-NIC | h | Gene Knockout | Puromycin | 1 | ||
Apolipoprotein A I/APOA1 Double Nickase Plasmid (h2) | sc-400499-NIC-2 | h | Gene Knockout | Puromycin | 1 | ||
apoL2 CRISPR/Cas9 KO Plasmid (h) | sc-411787 | h | Gene Knockout | GFP | 0 | ||
apoL2 HDR Plasmid (h) | sc-411787-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
apoL3 CRISPR/Cas9 KO Plasmid (h) | sc-407432 | h | Gene Knockout | GFP | 0 | ||
apoL3 HDR Plasmid (h) | sc-407432-HDR | h | Homology Directed Repair | Puromycin | 0 |
Apolipoprotein CRISPR Activation Products
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
apoA-II CRISPR Activation Plasmid (h) | sc-404987-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
apoA-II CRISPR Activation Plasmid (h2) | sc-404987-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
apoA-IV CRISPR Activation Plasmid (h) | sc-402217-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ApoA-V CRISPR Activation Plasmid (h) | sc-402213-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
apoB CRISPR Activation Plasmid (h) | sc-400705-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
apoC-I CRISPR Activation Plasmid (m) | sc-419163-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
apoC-I CRISPR Activation Plasmid (m2) | sc-419163-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
apoC-III CRISPR Activation Plasmid (h) | sc-403887-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
apoD CRISPR Activation Plasmid (h) | sc-402012-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
apoD CRISPR Activation Plasmid (h2) | sc-402012-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
apoD Lentiviral Activation Particles (h) | sc-402012-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
apoF CRISPR Activation Plasmid (h) | sc-407655-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
apolipoprotein E/apoE CRISPR Activation Plasmid (h) | sc-400860-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
apolipoprotein E/apoE CRISPR Activation Plasmid (h2) | sc-400860-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
apoC1 CRISPR Activation Plasmid (h) | sc-403713-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
apoL1 CRISPR Activation Plasmid (h) | sc-403137-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
apoL1 CRISPR Activation Plasmid (h2) | sc-403137-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Apolipoprotein A I/APOA1 CRISPR Activation Plasmid (h) | sc-400499-ACT | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
Apolipoprotein A I/APOA1 CRISPR Activation Plasmid (h2) | sc-400499-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
Apolipoprotein A I/APOA1 CRISPR Activation Plasmid (m) | sc-419158-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Apolipoprotein A I/APOA1 CRISPR Activation Plasmid (m2) | sc-419158-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |
Apolipoprotein siRNA, shRNA Plasmid and shRNA Lentiviral Particle Gene Silencers
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
apoA siRNA (h) | sc-41176 | h | Gene Silencing | N/A | 0 | ||
apoA shRNA Plasmid (h) | sc-41176-SH | h | Gene Silencing | Puromycin | 0 | ||
apoA shRNA (h) Lentivirale Partikel | sc-41176-V | h | Gene Silencing | Puromycin | 0 | ||
apoA-II siRNA (h) | sc-43617 | h | Gene Silencing | N/A | 0 | ||
apoA-II shRNA Plasmid (h) | sc-43617-SH | h | Gene Silencing | Puromycin | 0 | ||
apoA-II shRNA (h) Lentivirale Partikel | sc-43617-V | h | Gene Silencing | Puromycin | 0 | ||
apoA-IV siRNA (h) | sc-41178 | h | Gene Silencing | N/A | 0 | ||
apoA-IV shRNA Plasmid (h) | sc-41178-SH | h | Gene Silencing | Puromycin | 0 | ||
apoA-IV shRNA (h) Lentivirale Partikel | sc-41178-V | h | Gene Silencing | Puromycin | 0 | ||
apoA-IV siRNA (m) | sc-41179 | m | Gene Silencing | N/A | 0 | ||
apoA-IV shRNA Plasmid (m) | sc-41179-SH | m | Gene Silencing | Puromycin | 0 | ||
apoA-IV shRNA (m) Lentivirale Partikel | sc-41179-V | m | Gene Silencing | Puromycin | 0 | ||
apoA-V siRNA (h) | sc-44527 | h | Gene Silencing | N/A | 1 | ||
apoA-V shRNA Plasmid (h) | sc-44527-SH | h | Gene Silencing | Puromycin | 1 | ||
apoA-V shRNA (h) Lentivirale Partikel | sc-44527-V | h | Gene Silencing | Puromycin | 1 | ||
apoA-V siRNA (m) | sc-44869 | m | Gene Silencing | N/A | 1 | ||
apoA-V shRNA Plasmid (m) | sc-44869-SH | m | Gene Silencing | Puromycin | 1 | ||
apoA-V shRNA (m) Lentivirale Partikel | sc-44869-V | m | Gene Silencing | Puromycin | 1 | ||
apoAL siRNA (h) | sc-95593 | h | Gene Silencing | N/A | 0 | ||
apoAL shRNA Plasmid (h) | sc-95593-SH | h | Gene Silencing | Puromycin | 0 | ||
apoAL shRNA (h) Lentivirale Partikel | sc-95593-V | h | Gene Silencing | Puromycin | 0 | ||
apoB siRNA (h) | sc-41180 | h | Gene Silencing | N/A | 0 | ||
apoB shRNA Plasmid (h) | sc-41180-SH | h | Gene Silencing | Puromycin | 0 | ||
apoB shRNA (h) Lentivirale Partikel | sc-41180-V | h | Gene Silencing | Puromycin | 0 | ||
apoB siRNA (m) | sc-41181 | m | Gene Silencing | N/A | 0 | ||
apoB shRNA Plasmid (m) | sc-41181-SH | m | Gene Silencing | Puromycin | 0 | ||
apoB shRNA (m) Lentivirale Partikel | sc-41181-V | m | Gene Silencing | Puromycin | 0 | ||
apoC-I siRNA (h) | sc-97370 | h | Gene Silencing | N/A | 0 | ||
apoC-I shRNA Plasmid (h) | sc-97370-SH | h | Gene Silencing | Puromycin | 0 | ||
apoC-I shRNA (h) Lentivirale Partikel | sc-97370-V | h | Gene Silencing | Puromycin | 0 | ||
apoC-II siRNA (h) | sc-41184 | h | Gene Silencing | N/A | 0 | ||
apoC-II shRNA Plasmid (h) | sc-41184-SH | h | Gene Silencing | Puromycin | 0 | ||
apoC-II shRNA (h) Lentivirale Partikel | sc-41184-V | h | Gene Silencing | Puromycin | 0 | ||
apoC-II siRNA (m) | sc-41185 | m | Gene Silencing | N/A | 0 | ||
apoC-II shRNA Plasmid (m) | sc-41185-SH | m | Gene Silencing | Puromycin | 0 | ||
apoC-II shRNA (m) Lentivirale Partikel | sc-41185-V | m | Gene Silencing | Puromycin | 0 | ||
apoC-III siRNA (h) | sc-41186 | h | Gene Silencing | N/A | 0 | ||
apoC-III shRNA Plasmid (h) | sc-41186-SH | h | Gene Silencing | Puromycin | 0 | ||
apoC-III shRNA (h) Lentivirale Partikel | sc-41186-V | h | Gene Silencing | Puromycin | 0 | ||
apoC-III siRNA (m) | sc-60051 | m | Gene Silencing | N/A | 0 | ||
apoC-III shRNA Plasmid (m) | sc-60051-SH | m | Gene Silencing | Puromycin | 0 | ||
apoC-III shRNA (m) Lentivirale Partikel | sc-60051-V | m | Gene Silencing | Puromycin | 0 | ||
apoC-IV siRNA (h) | sc-41187 | h | Gene Silencing | N/A | 0 | ||
apoC-IV shRNA Plasmid (h) | sc-41187-SH | h | Gene Silencing | Puromycin | 0 | ||
apoC-IV shRNA (h) Lentivirale Partikel | sc-41187-V | h | Gene Silencing | Puromycin | 0 | ||
apoC-IV siRNA (m) | sc-41188 | m | Gene Silencing | N/A | 0 | ||
apoC-IV shRNA Plasmid (m) | sc-41188-SH | m | Gene Silencing | Puromycin | 0 | ||
apoC-IV shRNA (m) Lentivirale Partikel | sc-41188-V | m | Gene Silencing | Puromycin | 0 | ||
apoD siRNA (h) | sc-45518 | h | Gene Silencing | N/A | 0 | ||
apoD shRNA Plasmid (h) | sc-45518-SH | h | Gene Silencing | Puromycin | 0 | ||
apoD shRNA (h) Lentivirale Partikel | sc-45518-V | h | Gene Silencing | Puromycin | 0 | ||
apoD siRNA (m) | sc-45519 | m | Gene Silencing | N/A | 0 | ||
apoD shRNA Plasmid (m) | sc-45519-SH | m | Gene Silencing | Puromycin | 0 | ||
apoD shRNA (m) Lentivirale Partikel | sc-45519-V | m | Gene Silencing | Puromycin | 0 | ||
apoF siRNA (h) | sc-95822 | h | Gene Silencing | N/A | 0 | ||
apoF shRNA Plasmid (h) | sc-95822-SH | h | Gene Silencing | Puromycin | 0 | ||
apoF shRNA (h) Lentivirale Partikel | sc-95822-V | h | Gene Silencing | Puromycin | 0 | ||
apoF siRNA (m) | sc-141160 | m | Gene Silencing | N/A | 0 | ||
apoF shRNA Plasmid (m) | sc-141160-SH | m | Gene Silencing | Puromycin | 0 | ||
apoF shRNA (m) Lentivirale Partikel | sc-141160-V | m | Gene Silencing | Puromycin | 0 | ||
apoH siRNA (h) | sc-72518 | h | Gene Silencing | N/A | 0 | ||
apoH shRNA Plasmid (h) | sc-72518-SH | h | Gene Silencing | Puromycin | 0 | ||
apoH shRNA (h) Lentivirale Partikel | sc-72518-V | h | Gene Silencing | Puromycin | 0 | ||
apoH siRNA (m) | sc-72519 | m | Gene Silencing | N/A | 0 | ||
apoH shRNA Plasmid (m) | sc-72519-SH | m | Gene Silencing | Puromycin | 0 | ||
apoH shRNA (m) Lentivirale Partikel | sc-72519-V | m | Gene Silencing | Puromycin | 0 | ||
apoL siRNA (h) | sc-41189 | h | Gene Silencing | N/A | 4 | ||
apoL shRNA Plasmid (h) | sc-41189-SH | h | Gene Silencing | Puromycin | 4 | ||
apoL shRNA (h) Lentivirale Partikel | sc-41189-V | h | Gene Silencing | Puromycin | 4 | ||
apoL-IV siRNA (h) | sc-72520 | h | Gene Silencing | N/A | 0 | ||
apoL-IV shRNA Plasmid (h) | sc-72520-SH | h | Gene Silencing | Puromycin | 0 | ||
apoL-IV shRNA (h) Lentivirale Partikel | sc-72520-V | h | Gene Silencing | Puromycin | 0 | ||
apoL-V siRNA (h) | sc-72521 | h | Gene Silencing | N/A | 0 | ||
apoL-V shRNA Plasmid (h) | sc-72521-SH | h | Gene Silencing | Puromycin | 0 | ||
apoL-V shRNA (h) Lentivirale Partikel | sc-72521-V | h | Gene Silencing | Puromycin | 0 | ||
apoL-VI siRNA (h) | sc-72522 | h | Gene Silencing | N/A | 0 | ||
apoL-VI shRNA Plasmid (h) | sc-72522-SH | h | Gene Silencing | Puromycin | 0 | ||
apoL-VI shRNA (h) Lentivirale Partikel | sc-72522-V | h | Gene Silencing | Puromycin | 0 | ||
apolipoprotein E/apoE siRNA (h) | sc-29708 | h | Gene Silencing | N/A | 3 | ||
apolipoprotein E/apoE shRNA Plasmid (h) | sc-29708-SH | h | Gene Silencing | Puromycin | 3 | ||
apolipoprotein E/apoE shRNA (h) Lentivirale Partikel | sc-29708-V | h | Gene Silencing | Puromycin | 3 | ||
apolipoprotein E/apoE siRNA (m) | sc-29709 | m | Gene Silencing | N/A | 1 | ||
apolipoprotein E/apoE shRNA Plasmid (m) | sc-29709-SH | m | Gene Silencing | Puromycin | 1 | ||
apolipoprotein E/apoE shRNA (m) Lentivirale Partikel | sc-29709-V | m | Gene Silencing | Puromycin | 1 | ||
apoM siRNA (h) | sc-61978 | h | Gene Silencing | N/A | 2 | ||
apoM shRNA Plasmid (h) | sc-61978-SH | h | Gene Silencing | Puromycin | 2 | ||
apoM shRNA (h) Lentivirale Partikel | sc-61978-V | h | Gene Silencing | Puromycin | 2 | ||
apoM siRNA (m) | sc-61979 | m | Gene Silencing | N/A | 0 | ||
apoM shRNA Plasmid (m) | sc-61979-SH | m | Gene Silencing | Puromycin | 0 | ||
apoM shRNA (m) Lentivirale Partikel | sc-61979-V | m | Gene Silencing | Puromycin | 0 | ||
apoN siRNA (m) | sc-141174 | m | Gene Silencing | N/A | 0 | ||
apoN shRNA Plasmid (m) | sc-141174-SH | m | Gene Silencing | Puromycin | 0 | ||
apoN shRNA (m) Lentivirale Partikel | sc-141174-V | m | Gene Silencing | Puromycin | 0 | ||
apoO siRNA (h) | sc-90923 | h | Gene Silencing | N/A | 1 | ||
apoO shRNA Plasmid (h) | sc-90923-SH | h | Gene Silencing | Puromycin | 1 | ||
apoO shRNA (h) Lentivirale Partikel | sc-90923-V | h | Gene Silencing | Puromycin | 1 | ||
apoO siRNA (m) | sc-141175 | m | Gene Silencing | N/A | 0 | ||
apoO shRNA Plasmid (m) | sc-141175-SH | m | Gene Silencing | Puromycin | 0 | ||
apoO shRNA (m) Lentivirale Partikel | sc-141175-V | m | Gene Silencing | Puromycin | 0 | ||
apoOL siRNA (h) | sc-91074 | h | Gene Silencing | N/A | 0 | ||
apoOL shRNA Plasmid (h) | sc-91074-SH | h | Gene Silencing | Puromycin | 0 | ||
apoOL shRNA (h) Lentivirale Partikel | sc-91074-V | h | Gene Silencing | Puromycin | 0 | ||
apoOL siRNA (m) | sc-141176 | m | Gene Silencing | N/A | 0 | ||
apoOL shRNA Plasmid (m) | sc-141176-SH | m | Gene Silencing | Puromycin | 0 | ||
apoOL shRNA (m) Lentivirale Partikel | sc-141176-V | m | Gene Silencing | Puromycin | 0 | ||
apoLD1 siRNA (h) | sc-96047 | h | Gene Silencing | N/A | 0 | ||
apoLD1 shRNA Plasmid (h) | sc-96047-SH | h | Gene Silencing | Puromycin | 0 | ||
apoLD1 shRNA (h) Lentivirale Partikel | sc-96047-V | h | Gene Silencing | Puromycin | 0 | ||
apoLD1 siRNA (m) | sc-141173 | m | Gene Silencing | N/A | 0 | ||
apoLD1 shRNA Plasmid (m) | sc-141173-SH | m | Gene Silencing | Puromycin | 0 | ||
apoLD1 shRNA (m) Lentivirale Partikel | sc-141173-V | m | Gene Silencing | Puromycin | 0 | ||
Apolipoprotein A I/APOA1 siRNA (h) | sc-41177 | h | Gene Silencing | N/A | 0 | ||
Apolipoprotein A I/APOA1 shRNA Plasmid (h) | sc-41177-SH | h | Gene Silencing | Puromycin | 0 | ||
Apolipoprotein A I/APOA1 shRNA (h) Lentivirale Partikel | sc-41177-V | h | Gene Silencing | Puromycin | 0 | ||
Apolipoprotein A I/APOA1 siRNA (m) | sc-63361 | m | Gene Silencing | N/A | 1 | ||
Apolipoprotein A I/APOA1 shRNA Plasmid (m) | sc-63361-SH | m | Gene Silencing | Puromycin | 1 | ||
Apolipoprotein A I/APOA1 shRNA (m) Lentivirale Partikel | sc-63361-V | m | Gene Silencing | Puromycin | 1 | ||
apoL2 siRNA (h) | sc-60192 | h | Gene Silencing | N/A | 0 | ||
apoL2 shRNA Plasmid (h) | sc-60192-SH | h | Gene Silencing | Puromycin | 0 | ||
apoL2 shRNA (h) Lentivirale Partikel | sc-60192-V | h | Gene Silencing | Puromycin | 0 | ||
apoL3 siRNA (h) | sc-60193 | h | Gene Silencing | N/A | 0 | ||
apoL3 shRNA Plasmid (h) | sc-60193-SH | h | Gene Silencing | Puromycin | 0 | ||
apoL3 shRNA (h) Lentivirale Partikel | sc-60193-V | h | Gene Silencing | Puromycin | 0 | ||
apoL7b siRNA (m) | sc-141169 | m | Gene Silencing | N/A | 0 | ||
apoL7b shRNA (m) Lentivirale Partikel | sc-141169-V | m | Gene Silencing | Puromycin | 0 | ||
apoL11b siRNA (m) | sc-156063 | m | Gene Silencing | N/A | 0 | ||
apoL11b shRNA Plasmid (m) | sc-156063-SH | m | Gene Silencing | Puromycin | 0 | ||
apoL11b shRNA (m) Lentivirale Partikel | sc-156063-V | m | Gene Silencing | Puromycin | 0 |